Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.
Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) Earnings per Share (EPS) (Diluted) data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Earnings per Share (EPS) (Diluted) |
-- |
| Balance Sheet Financials | |
$56.80M |
|
-- |
|
-- |
|
$56.80M |
|
$257.87M |
|
-- |
|
-- |
|
$257.87M |
|
$-201.07M |
|
$-201.07M |
|
$-201.07M |
|
-- |
|
| Cash Flow Statement Financials | |
$-158.64M |
|
$-0.01M |
|
$34.77M |
|
$172.47M |
|
$48.44M |
|
$-124.03M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|